This explanation is in line with the conclusions of Padovan-Neto et al. [29] who reported that in 6-OHDA treated rats L-dopa-induced a dyskinesia accompanied by an increase in nNOS expression. Here, NOS1 is linked to drug-induced dyskinesia.